Previous close | 0.5100 |
Open | 0.5110 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.4615 - 0.5480 |
52-week range | 0.4010 - 1.0790 |
Volume | |
Avg. volume | 170,085 |
Market cap | 17.126M |
Beta (5Y monthly) | 2.56 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0800 |
Earnings date | 13 Apr 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 1.60 |
PARIS & BOULDER, Colo., May 16, 2023--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, and XinRong Medical Group, a China leader in medical technology, announced today that they expanded their collaboration with the signature of three concomitant agreements:
PARIS & BOULDER, Colo., April 28, 2023--Regulatory News: SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announces that its Annual Shareholders’ Meeting will be held on Thursday June 8, 2023 at 10:00am CEST at the offices of the law firm Ashurst located in Paris, at 18, Square Edouard VII, 75009 (France) and inform on its voting modalities.
PARIS & BOULDER, Colo., April 13, 2023--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announced today its full-year 2022 financial results, as approved by the Board of Directors on April 13, 2023, and its first quarter 2023 sales.
PARIS & BOULDER, Colo., March 08, 2023--Regulatory News: SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, today announced new impressive results reached in the development of its robotic application.
PARIS & BOULDER, Colo., January 09, 2023--Regulatory News: SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, reported today its full-year 2022 revenue.
PARIS & BOULDER, Colo., January 05, 2023--Regulatory News: SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announced today its schedule for the publication of financial information for 2023.
PARIS & BOULDER, Colo., December 13, 2022--Regulatory News: SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announced today that two researchers, the surgeon Elie Saghbiny and the engineer Jimmy Da Silva, were recognized for their collaborative work led jointly by the ISIR (Institute for Intelligent and Robotic Systems) lab of Sorbonne University an
PARIS & BOULDER, Colo., October 04, 2022--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announced today that its revenue was € 1.5 M in the third quarter up 44% and € 4.0 M YTD up 24%.
PARIS & BOULDER, Colo., September 15, 2022--Regulatory News: SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announced today financial results for the half year ending June 30, 2022, as approved by the Board of Directors on September 15, 2022.
MORGANTOWN, W.Va. & BOULDER, Colo. & PARIS, September 12, 2022--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, and Omnia Medical, a medical device company focused on innovative solutions utilizing proven techniques, announced today the signature of a co-development and exclusive distribution agreement for adult spine surgery in the United States
PARIS & BOULDER, Colo., August 02, 2022--Regulatory News: SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, today announced a change in its financial calendar for the second half of 2022.
PARIS & BOULDER, Colo., July 12, 2022--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announced today its first half 2022 revenue.
PARIS & BOULDER, Colo., June 30, 2022--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, reports on its Annual Shareholders’ Meeting held on June 30, 2022, at 10:00am, on its second call at the offices of the law firm Ashurst Paris, located at 18 square Edouard VII, 75009 Paris.
PARIS & BOULDER, Colo., June 08, 2022--Regulatory News: SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announces that, due to lack of quorum, its Annual Shareholders’ meeting held on June 8, 2022 could not be held.
PARIS & BOULDER, Colo., June 07, 2022--Regulatory News: SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announces the launch of a new three-year collaboration program with two labs of Sorbonne University CNRS and Inserm: the ISIR (Institute for intelligent systems and robotics) and LIB (Laboratory for biomedical imaging).